Starton Therapeutics Reports Positive Results From Phase 1 Study Evaluating Star-Lld Continuous Delivery Lenalidomide
Star-Lld Well Tolerated With No Dose-Related Toxicity Or Adverse EventsStar Lld Achieved 90% Bioavailability Across All DosesPlasma Levels Showed A 90% Lower Cmax, A 70% Lower Auc, And Sustained Cmin At Targeted Dose LevelsStudy Validated Compatibility And Utility Of Ambulatory Pump Delivery System With Star-Lld Subcutaneous FormulationStarton Therapeutics Inc., A Clinical Stage Biotechnology Company Announced Today Positive Results From High-Level Data From Its Phase 1 Study Of Star-Lld, Evaluating The Pharmacokinetics (Pk) And Safety Of The Company
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
